BACKGROUND: Well-differentiated thyroid carcinoma has a favorable prognosis, but patients with multiple recurrences have drastically lower survival. Filipinos in the United States are known to have high rates of thyroid cancer incidence and disease recurrence. To the authors' knowledge, it is unknown whether Filipinos also have higher thyroid cancer mortality rates. METHODS: The authors studied thyroid cancer mortality in Filipino, non-Filipino Asian (NFA), and non-Hispanic white (NHW) adults using US death records (2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012) and US Census data. Age-adjusted mortality rates and proportional mortality ratios (PMRs) were calculated. Sex, nativity status, age at death, and educational attainment also were examined. RESULTS: The authors examined 19,940,952 deaths. The ageadjusted mortality rates due to thyroid cancer were highest in Filipinos (1.72 deaths per 100,000 population; 95% confidence interval [95% CI], 1.51-1.95) compared with NFAs (1.03 per 100,000 population; 95% CI, 0.95-1.12) and NHWs (1.17 per 100,000 population; 95% CI, 1.16-1.18). Compared with NHWs, higher proportionate mortality was observed in Filipino women (3-5 times higher) across all age groups, and among Filipino men, the PMR was 2 to 3 times higher in the subgroup aged >55 years. Filipinos who completed a higher educational level had a notably higher PMR (5.0) compared with their counterparts who had not (3.5). CONCLUSIONS: Negative prognostic factors for thyroid cancer traditionally include age >45 years and male sex. The results of the current study demonstrate that Filipinos die of thyroid cancer at higher rates than NFA and NHW individuals of similar ages. Highly educated Filipinos and Filipino women may be especially at risk of poor thyroid cancer outcomes. Filipino ethnicity should be factored into clinical decision making in the management of patients with thyroid cancer. Cancer 2017;123:4860-7.
INTRODUCTION
Major prognostic factors considered for thyroid cancer are age, tumor size, multifocal disease, extrathyroidal extension, and distant metastases. 1 Despite a large body of literature demonstrating that individuals of Filipino heritage (hereafter referred to as Filipinos) have an increased thyroid cancer incidence, [2] [3] [4] [5] [6] to our knowledge few studies to date have examined whether Filipinos also have higher thyroid cancer mortality rates compared with other racial/ethnic groups.
With a population of 3.4 million as of 2010, Filipinos are the second largest Asian population residing in the United States, and comprise nearly 20% of all Asian Americans. 7 The majority of cancer databases group all Asian subgroups together for data collection and analyses. This type of grouping can mask disparities; lead to a dearth of information regarding specific subgroups; and limit evidence-based cancer control, prevention, and intervention measures within these diverse populations. 8 Recent work by Kus et al 9 has demonstrated that Filipinos in Canada have a significantly increased risk of thyroid cancer recurrence compared with all other racial/ethnic groups, even when adjusting for confounding factors such as sex, age, history of head and neck radiotherapy, and type of thyroid surgery (odds ratio [OR], 6.99; 95% confidence interval [95% CI], 2.31-21.1). In the same study, approximately 5.6% of the Filipino cohort died of thyroid cancer versus 1.9% of the non-Filipino cohort, a result that was not statistically significant, most likely due to the relatively small sample size (499 patients) and the difficulty in studying mortality among patients with a disease with a favorable prognosis. 9 A retrospective analysis performed at the Philippines General Hospital also found a higher rate of disease recurrence among Filipinos (30.1%) compared with Korean (17.5%) and Japanese (9.6%) populations studied by other research groups. 4 To the best of our knowledge, it remains unclear whether the higher recurrence rate observed in Filipinos also leads to a difference in mortality due to thyroid cancer in the United States.
Individuals diagnosed with well-differentiated thyroid carcinoma are considered to have an excellent prognosis, but a subgroup of patients experience multiple treatment failures and/or thyroid cancer recurrences. These individuals have significantly higher rates of death from the disease compared with those with 1 or no treatment failures (20-year disease-specific survival rate of 60% vs 94%-100%, respectively). 10 Preemptive identification of individuals who are more likely to die of thyroid cancer based on demographic characteristics such as race/ ethnicity is imperative to help clinicians create effective customized treatment and monitoring plans.
We used 10 years of national mortality data to examine age-adjusted mortality rates (AMRs) and proportional mortality ratios (PMRs) due to thyroid cancer in Filipinos compared with non-Filipino Asian (NFA) and nonHispanic white (NHW) individuals with the hypothesis that the AMR and PMR would be higher in Filipinos. To our knowledge, the current study is the first to use national mortality data to evaluate death due to thyroid cancer in Filipinos in the United States. Findings from the current study will inform clinical management guidelines and empower clinicians and policy makers to bridge the gap in thyroid cancer outcomes for Filipinos.
MATERIALS AND METHODS

Study Population
Causes of death, race/ethnicity, and sex were identified using the Multiple Cause of Death File of the National Center for Health Statistics from 2003 to 2012. This database includes the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) codes for both the underlying cause of death and up to 20 relevant conditions. ICD-10 codes were mapped into 260 categories using the Clinical Classifications Software, a tool developed at the Agency for Healthcare Research and Quality for clustering patient diagnoses into clinically meaningful categories. Death due to thyroid cancer was defined as having Clinical Classifications Software code 36 (ie, "cancer of the thyroid") as the underlying cause of death or as 1 of the 20 conditions. Decedents who were aged 18 years at the time of death were selected. Cancer deaths were defined using ICD-10 code C00-C97 from all conditions. Decedent characteristics consisted of racial/ethnic group (ie, Filipino, NFA, and NHW), number of deaths due to any cancer or thyroid cancer alone, median and mean age at the time of death, percentage of females, percentage who were foreign born, and educational attainment. Educational attainment was classified into 5 categories from both the 2003 and 1989 revisions, considering that different states adopted different revisions. The categorizations were: 1) no formal education; 2) high school or General Educational Development (GED) completed; 3) some college; 4) Bachelor's degree; and 5) unknown. To assess statistical significance, chi-square tests were used for categorical variables and analysis of variance tests were used for continuous variables. Differences between medians were assessed using the Wilcoxon rank sum test (Mann-Whitney U test).
Age at the time of death was categorized into 1 of the following 6 age groups: 1) aged 18 to 44 years; 2) aged 45 to 54 years; 3) aged 55 to 64 years; 4) aged 65 to 74 years; 5) aged 75 to 84 years; and 6) aged 85 years. A decedent's nativity status was defined as "US born" if the decedent was born within the 50 states or Washington DC, and as "foreign born" if the decedent was born outside of the United States or in 1 of the US territory islands (ie, Puerto Rico, Virgin Islands, Guam, American Samoa, and Northern Marianas).
Statistical Analysis
Thyroid cancer AMRs per 100,000 population were calculated using direct standardization to the 2000 US standard population, and were compared across racial/ethnic groups by sex. Population estimates were derived using linear interpolation from 2000 and 2010 US Census data. The percentages of deaths due to any cancer and thyroid cancer alone were calculated for each racial/ethnic group. The PMR was defined as the percentage of deaths due to thyroid cancer in a specified racial/ethnic group divided by the percentage of deaths due to thyroid cancer for all NHW individuals (ie, men and women combined). PMRs were compared across racial/ethnic groups by nativity and educational attainment (collapsed into the 2 categories of "no Bachelor's degree" and "Bachelor's degree"), as well as for each combination of age group and sex. For AMRs, we reported P values for pairwise differences (ie, Filipino vs NFA, NFA vs NHW, and NHW vs Filipino), overall and by sex. For PMRs, we reported P values for testing whether the PMRs in specific groups were different from the PMR of all NHWs (see Supporting Information material). Thyroid cancer mortality (ie, AMR and the percentage of deaths due to thyroid cancer) was reported for other Asian subgroups as a sensitivity analysis in Supporting Information Table 1 .
All analyses were performed using R statistical software (R Foundation, Vienna, Austria) and SAS statistical software (version 9.4; SAS Institute Inc, Cary, North Carolina), and statistical tests were based on 2-sided tests with a significance level of .05 unless otherwise noted. P values and 95% CIs corresponding to the a priori hypotheses that the AMR and PMR of Filipinos are different from (ie, higher than) those of NFAs and NHWs are confirmatory findings. All other P values and 95% CIs (eg, from analyzing subgroups such as by sex or age) are exploratory in nature and should be confirmed in followup studies.
RESULTS
We examined 19,940,952 US death records from 2003 to 2012. The number of total deaths, deaths due to any cancer, deaths due to thyroid cancer, and average annual population estimates are presented by racial/ethnic group in Table 1 . Demographic information (ie, age at the time of death, sex, nativity status, and educational attainment) also is presented in Table 1 . Both the median and mean age at the time of death were not found to be significantly different between Filipinos and the referent groups. Compared with NFA and NHW decedents, more Filipinos were foreign born (90.2% vs 76.0% and 6.1%, respectively). Filipino decedents also had higher educational attainment compared with other racial/ethnic groups: 32.3% had obtained a Bachelor's degree or higher versus 22.3% of NFAs and 14.6% of NHWs (Table 1) . Percentages of deaths due to cancer were similar across all groups. The percentage of deaths due to thyroid cancer was 0.31% in Filipinos, which was 1.8 times and 3.9 times higher, respectively, than that of NFAs (0.17%) and NHWs (0.08%).
The following AMR and PMR results are reported in Table 2 . Overall, PMR due to thyroid cancer tended to be higher in foreign-born populations (Table 2) . PMR due to thyroid cancer was 4.1 in foreign-born Filipinos and 2.6 in US-born Filipinos. Foreign-born NFAs had a PMR of 2.3 versus their US-born counterparts, who had a PMR of 1.8. Compared with NFAs and NHWs, Filipinos had the highest AMR for thyroid cancer of 1.72; the AMR for NFAs was 1.03, and was 1.17 for NHWs. Filipinos who had completed a Bachelor's degree had a notably higher PMR (5.0) compared with Filipinos who had not (3.5) . Similarly, NHWs who had completed a Bachelor's degree also had a notably higher PMR (1.5) compared with NHWs who had not (0.9). Nevertheless, Filipinos of any educational status had the highest PMRs of all the comparison groups.
PMRs by racial/ethnic group and age group (separated by sex) are illustrated in Figure 1 . Among men, PMRs for Filipinos were similar to those of comparison groups of younger age at the time of death (aged 18-64 years), and approximately 2 to 3 times higher when older at the time of death (aged > 64 years) (Fig. 1A) . Among women, Filipinos had the highest PMRs at every age, and 
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NHWs had the lowest PMRs at every age (Fig. 1B) . Filipino women had higher PMRs than Filipino men at all ages. For Filipinos, the female PMR was approximately 7 times, 3 times, and 2 times, respectively, the male PMR for decedents aged <45 years, those aged 45 to 64 years, and those aged 64 years at the time of death. Other findings by racial/ethnic group and age group are reported as follows. NFA women also had higher PMRs than NFA men at all ages. NHW women aged < 45 years at the time of death had higher PMRs than all NHW men, but the PMRs were similar between NHW women and men at older ages (results not shown). As expected, the total number of deaths due to thyroid cancer in individuals aged <45 years was small (see Supporting Information Table 2 ).
In summary, Filipino race/ethnicity is associated with higher rates of death from thyroid cancer, even when adjusted for age. Among all Filipino decedents, having been highly educated or a woman corresponded with particularly high proportionate mortality compared with all other groups. In supplementary sensitivity analysis (see Supporting Information Table 1 ), we did not find any comparable disparities in mortality outcomes among other disaggregated Asian American subgroups (ie, Asian Indian, Chinese, Japanese, Korean, and Vietnamese).
It is interesting to note that due to the large sample sizes involved in the current analysis, we expected the majority of P values to be very small, thereby providing statistical evidence that a difference exists. However, statistical significance does not suggest scientific importance. In fact, findings with large P values might be more informative in this setting; they could indicate that the true difference, if it exists, is perhaps so small as to not be detectable even with a sample as large as that presented herein.
DISCUSSION
Why Filipinos?
To the best of our knowledge, the mechanism behind the increased rates of disease recurrence noted among Filipino patients with thyroid cancer remains unclear, but past studies have theorized that cultural factors, such as diet, or environmental exposures are responsible for the higher incidence of thyroid cancer observed in Filipino individuals. 3, 11, 12 Studies examining diet and thyroid cancer outcome are scarce. Patients with thyroid cancer who have undergone thyroidectomy often are placed on low-iodine diets before radioactive iodine (RAI) treatment to enhance iodine-131 uptake and maximize the destruction of cancerous thyroid cells. 13 One study found that among a cohort of Korean females, approximately 37% did not know that fish pastes, hams, and sausages contained high levels of iodine, and 36% overestimated the amount of dairy they were allowed to consume on a low-iodine diet. 14 It is plausible that Filipino patients have similar misunderstandings and a higher intake of iodine-rich foods such as seafood and dairy than other patients preparing for RAI treatment, which may render the treatment less effective or may modulate tumor behavior.
We did not identify a scientific difference in proportionate mortality between foreign-born Filipinos and their US counterparts. This makes environmental exposures present in the Philippines, such as carcinogenic volcanic lava, 11, 15 unlikely to explain the differential outcomes we observed.
Filipinos had higher educational attainment than other comparison groups in the current study, and highly educated Filipinos had higher proportionate mortality due to thyroid cancer. Many Filipino immigrants who arrived in the United States in the 1970s and 1980s were health professionals. 16 Up until the mid-1980s, Filipino nurses represented approximately 75% of all foreign nurses in the US nurse workforce. 17 Consequently, it is possible that occupational exposures within hospitals, such as radiation, could be leading to the disproportionately worse outcomes noted within this population. A retrospective chart review by Seaberg et al found that patients who had prior radiation exposure, including both acute high-dose and chronic low-dose exposure, had a higher percentage of multifocal disease, extrathyroidal spread, stage IV disease, and death. 18 Conversely, other studies have not found any relationship between prior radiation exposure and clinical outcome. [19] [20] [21] [22] Higher education may be a proxy for other factors that influence clinical outcome, such as an exposure specific to a generation of immigrants, different approaches to accessing health care, or other behavioral habits.
Perhaps the most plausible explanation for the differential thyroid cancer outcomes observed among Filipino individuals is the existence of a genetic predisposition in the host and/or tumor. Recent work by the Cancer Genome Atlas Research Network has drastically increased our understanding of the genetic basis of thyroid cancer behavior. 23 Alterations and gene expression patterns of specific genes (ie, telomerase reverse transcriptase [TERT], CHEK2, and ATM) and sets of functionally related genes have been shown to define clinical subclasses of thyroid cancer and may contribute to loss of differentiation and tumor progression. 23 For example, TERT promoter mutations and increased expression of a specific microRNA (miR-21) were linked to aggressive forms of papillary thyroid carcinoma. Filipinos may carry an allele that predisposes them as a population toward the somatic mutations that drive thyroid tumor aggressiveness.
Sex and Prognosis
Among both Filipinos and NFAs, women had higher PMRs than men at all ages. Filipino women had especially high proportionate mortality compared with other racial/ ethnic/sex groups at all ages. Given the sex differences we observed in the current study, it is plausible that an Xlinked allele could be predisposing Filipino women toward more aggressive thyroid cancer. The findings of the current study differ from the popularly held belief that men have poorer outcomes when diagnosed with thyroid cancer. 24 It is interesting to note that many of these studies analyzed patient cohorts from single medical Figure 1 . Proportional mortality ratios (PMRs) due to thyroid cancer by sex and age group. PMRs are shown by age group for Filipino, non-Filipino Asian, and non-Hispanic white (A) men and (B) women. Older Filipino men appeared to have a higher PMR compared with other men. At all ages, Filipino women appeared to have a much higher PMR than the comparison groups. PMR was defined as the percentage of deaths due to thyroid cancer in a specified racial/ethnic/sex group divided by the percentage of deaths due to thyroid cancer for all non-Hispanic white individuals.
institutions outside of the United States. For example, Ito and Miyauchi found that Japanese men with thyroid cancer died of the disease at greater than twice the rate as women (hazard ratio of 2.88 for cause-specific survival). 24 Lin et al found that among Chinese patients with distant metastases who died of thyroid cancer, older patients and men represented a larger percentage. 25 Conversely, a later study by Ito et al found that male sex was not predictive of death. 26 
Study Limitations
The volume of individuals included in 10 years of US death records allowed us to feasibly examine AMRs and proportional mortality due to thyroid cancer, a disease with a low overall mortality rate. As expected, the number of individuals aged <45 years who died of thyroid cancer was small (see Supporting Information Table 2 ). Thus, it is unclear whether the PMR we estimated for this population is robust. However, the number of decedents in the current study sample was sufficiently large to examine many important strata, such as older age, sex, educational attainment, and nativity.
Other limitations of the current study include using data based on national death certificates, which may misclassify race/ethnicity 27 and contain errors in the documented cause of death. 28 A recent study reported that misclassification may account for up to 3% of the US death certificates for Asian or Pacific Islander individuals. 29 Census data also exhibit misclassification of race/ ethnicity, which may have affected the AMRs. 30 Nonetheless, race/ethnicity reporting by the US Census is based on self-report, which is the gold standard. One of the advantages of the PMR approach is that a single data source is used (death records only) rather than both data sources, which may minimize the effects of race/ethnicity misclassification.
Estimates of the frequency of incorrect diagnoses have been highly variable given that, to our knowledge, there is no gold standard (ie, actual cause of death) with which to compare a reported cause of death. 28 Past studies have shown that there is greater reliability in cause-ofdeath reporting when studying cancer compared with other causes of death. 28 The approach in the current study also was limited by its dependence on ICD-10 diagnostic coding, which does not differentiate histopathological subtypes of thyroid cancer. A study based on data from the Surveillance, Epidemiology, and End Results 13 registry database found that approximately 85% of thyroid cancers diagnosed in the United States from 1992 to 2006 were papillary thyroid carcinomas. The same study observed that Asians in the United States had the highest incidence rate of papillary carcinoma compared with other racial/ ethnic groups. Racial/ethnic differences in the incidence of anaplastic thyroid cancer, the subtype with the worst prognosis, was found to be less pronounced but highest in Hispanic and Asian individuals. 31 The study did not disaggregate Filipinos from other Asians. Given this information, the majority of deaths due to thyroid cancer were likely due to papillary carcinoma or anaplastic thyroid cancer, although due to the limitations of ICD-10 coding, we were unable to study racial/ethnic differences by histopathological subtype.
We accounted for confounding by age through age adjustment in calculating AMRs, and by sex, nativity status, and educational attainment by making stratified comparisons of AMR (Table 2 ). However, we could not account for a few other potential confounders of mortality, such as stage of disease at the time of diagnosis, age at the time of diagnosis, type of cancer treatment (ie, extent of thyroidectomy and neck dissection, RAI), socioeconomic status, level of acculturation, or occupational and environmental exposures, given our use of data from death certificates. Information related to diet and environmental exposures (ie, radiation) also was not available to help inform potential explanations for differences in outcome.
Future Steps
Future studies of thyroid cancer prognosis should include individuals of Filipino ethnicity separate from other Asians and Pacific Islanders to further validate the current study findings in different cohorts and richer cancer databases.
To investigate pathophysiology, future studies also should examine whether aggressive histopathological subtypes (such as anaplastic thyroid cancer or the tall cell variant of papillary thyroid carcinoma) and genetic alterations associated with thyroid dedifferentiation and tumor progression (such as TERT promoter mutations) are more common in thyroid cancers surgically removed from Filipinos. Genetic epidemiology studies should investigate whether Filipinos as a population carry a higher percentage of any specific allele that predisposes them toward aggressive thyroid tumors. Investigations of this type would provide invaluable information regarding the pathophysiology of aggressive thyroid cancer, could support clinical decision making, and could lead to more targeted thyroid cancer treatment plans for this population.
Conclusions
Filipinos represent approximately 20% of the Asian American population in the United States, 7 and approximately 10.2 million Filipinos live and work outside of the Philippines worldwide. 32 Despite convincing evidence that Filipinos have a higher incidence of thyroid cancer and worse outcomes when diagnosed with thyroid cancer, to the best of our knowledge no clinical guidelines include Filipino ethnicity as a potential prognostic factor. The results of the current analysis suggest that Filipino ethnicity is associated with higher rates of death from thyroid cancer independent of age. Filipino women in particular may be at a higher proportionate risk of death from thyroid cancer. We hope that the current study findings will better inform and empower researchers, clinicians, prevention specialists, and policy makers to bridge the gap in thyroid cancer outcomes for Filipinos. 
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